Roni Mamluk
CIK: 0001647053
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RDHL
RedHill Biopharma Ltd.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Mamluk Roni
Mamluk Roni (SEC CIK 0001647053) files insider reports with the SEC as Director of RedHill Biopharma Ltd. (RDHL).
Signal8 holds 1 ownership filing by Mamluk Roni, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Mamluk Roni's filings is in TEL AVIV.
Other insiders filing for RedHill Biopharma Ltd. (RDHL)
- Raday Gilead, Chief Operating Officer
- Tsimchi Ofer, Director
- Scruggs Rick D, Chief Commercial Officer
- Reed Kenneth, Director
- Ingber Razi, Chief Financial Officer
- Goldberg Guy Joel, Chief Business Officer